Hunan Er-Kang Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
502
351
2,120
992
1,412
1,458
Total Accounts Receivable
180
262
302
356
508
517
Inventories
125
332
566
767
704
893
Other Current Assets
59
29
48
137
101
191
Total Current Assets
866
974
3,037
2,252
2,725
3,059
Net Property, Plant & Equipment
493
997
1,475
2,547
2,581
2,613
Total Investments and Advances
20
26
25
263
91
68
Intangible Assets
49
196
239
299
294
276
Other Assets
12
11
7
33
13
17
Total Assets
1,447
2,221
4,801
5,417
5,720
6,049
ST Debt & Current Portion LT Debt
-
160
295
6
-
Accounts Payable
19
71
69
189
89
Income Tax Payable
13
15
17
16
10
Other Current Liabilities
62
66
112
139
146
Total Current Liabilities
94
311
493
350
245
Long-Term Debt
-
200
-
-
-
Deferred Taxes
-
7
6
6
10
Total Liabilities
94
522
505
365
262
Common Equity (Total)
1,327
1,622
4,184
4,935
5,367
Total Shareholders' Equity
1,327
1,622
4,184
4,935
5,367
Total Equity
1,334
1,678
4,257
4,996
5,412
Liabilities & Shareholders' Equity
1,447
2,221
4,801
5,417
5,720
Accumulated Minority Interest
7
56
74
62
45
Non-Equity Reserves
19
20
39
57
47
About Hunan Er-Kang Pharmaceutical Co.
View Profile
